Bringing the fundamentals into focus…
Back to Ligand Pharmaceuticals Incorporated
How Ligand Pharmaceuticals Incorporated stacks up
LGND · against 213 other Healthcare companies of similar size
Profitability
86/ 100
Near the top of its peers.
Ranked #29 of 214 · scores higher than 85% of peers
Bars: peers in each 10-point band of the profitability score37 peers with a profitability score of 80–89, including LGND · Click a bar to see the companies
Why profitability scores 86?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its operating margin and return on assets, which are stronger than most Healthcare peers.
- Return on invested capital is close to the peer norm. Return on invested capital: 6.9% vs peer median 4.7%
- a higher return on assets: stronger than 88% of peers. Return on assets: 9.0% vs peer median 1.7%
- a wider operating margin: stronger than 95% of peers. Operating margin: 32.6% vs peer median 7.1%
Metric by metric
Position: dot = LGND, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | LGND | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 206 reported | 6.9% | 9.1% | 40% | 33% | |
| Operating marginHigher is better · 197 reported | 32.6% | 12.7% | 95% | 33% | |
| Return on assetsHigher is better · 204 reported | 9.0% | 4.1% | 86% | 33% | |
| Return on equityHigher is better · 199 reported | 22.0% | 8.5% | 87% | Context only | |
| Gross marginHigher is better · 223 reported | 81.2% | 51.0% | 89% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around LGNDScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score